Dr. Sattva S. Neelapu, Senion Clinical & Scientific Advisor, is currently an Associate Professor (effective Sept 1st, 2011) in the Department of Lymphoma and Myeloma at The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. He obtained his medical degree in India and subsequently moved to the United States of America where he completed residency in Internal Medicine at Coney Island Hospital, Brooklyn, New York, and clinical fellowship in Medical Oncology and postdoctoral fellowship in tumor immunology and immunotherapy at the National Cancer Institute, National Institutes of Health, Bethesda, Maryland. In 2004, he joined the faculty of the Department of Lymphoma and Myeloma at M. D. Anderson Cancer Center and has continued his clinical and laboratory research in immunotherapy and tumor immunology. He has conducted numerous therapeutic cancer vaccine clinical trials in patients with lymphoma and myeloma. His laboratory is now focused on characterization of immunoregulatory mechanisms in the tumor microenvironment in patients with lymphoma and development of novel therapeutic strategies for patients with lymphoma. His research is supported and recognized by numerous awards from national and international organizations including the National Institutes of Health, American Society of Clinical Oncology, American Association for Cancer Research, American Society of Hematology, Doris Duke Charitable Foundation, and Leukemia and Lymphoma Society.